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Fratricide among CD81 T Lymphocytes
Naturally Infected with Human
T Cell Lymphotropic Virus Type I
associated diseases. Although the cellular receptor for
HTLV-I has been mapped to chromosome 17 (Sommer-
felt et al., 1988), the molecule has not yet been identified.
HTLV-I can infect a wide range of human cell types in
vitro (Sommerfelt et al., 1988), but in vivo the virus is
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Okinawa 903-0215 raises the important possibility that it could become
Japan susceptible to lysis by HTLV-I-specific CTLs (Barchet
et al., 2000) or NK cells (De Vecchis et al., 1985) in vivo.
In this study, we provide direct evidence that HTLV-I
infects CD81 T lymphocytes (including HTLV-I-specific
Summary CD81 T cells) in vivo and renders them susceptible to
autologous CTLs ex vivo. The ability of CD81 T cells
Infection and gene expression by the human T lympho- to kill neighboring CD81 T cells (fratricide) has been
tropic virus type I (HTLV-I) in vivo have been thought previously reported in vitro using cell lines (Walden and
to be confined to CD41 T lymphocytes. We show here Eisen, 1990; Su et al., 1993; Huang et al., 1999) or CTLs
that, in natural HTLV-I infection, a significant propor- obtained from TCR transgenic mice and infected with
tion of CD81 T lymphocytes are infected by HTLV-I. recombinant viruses (Raftery et al., 1999). These artificial
Interestingly, HTLV-I-specific but not Epstein-Barr vi- systems may not be representative of a normal viral
rus–specific CD81 T lymphocytes were shown to be infection in vivo. The data presented here demonstrate
infected. Furthermore, HTLV-I protein expression in that fratricide can occur between naturally infected
naturally infected CD81 T lymphocytes renders them CD81 T lymphocytes and autologous CTLs obtained
susceptible to fratricide mediated by autologous HTLV- from HTLV-I-infected individuals.
I-specific CD81 T lymphocytes. Fratricide among vi-
rus-specific CTLs could impair the immune control of
ResultsHTLV-I and possibly other lymphotropic viruses.
Infection of CD81 T Lymphocytes by HTLV-IIntroduction
Short-term cultivation of PBMCs obtained from HTLV-
I-infected patients is associated with increased Tax pro-Human T cell lymphotropic virus type 1 (HTLV-I) is a
tein expression in CD41 T lymphocytes (Hanon et al.,human retrovirus that infects approximately 10–20
2000). We have recently devised a sensitive flow cyto-million people worldwide. The majority (about 95%) of
metric technique to detect Tax expression withininfected individuals develop no associated disease
PBMCs (Hanon et al., 2000). The specificity of this assay(asymptomatic carriers; ACs). However, in a small frac-
is shown in Figure 1A. Detection of Tax expression intion of individuals, infection results in one of two types
MT-2 cells, which are chronically infected with HTLV-I,of disease: about 2%–4% develop adult T cell leukemia
showed 99.8% of positive cells. The use of this assay(ATL), and a further 2%–4% develop one or more of a
on PBMCs isolated from an uninfected patient showedrange of inflammatory diseases. The most common of
0.0% of Tax-expressing cells. In contrast, PBMCs iso-these conditions is HTLV-I-associated myelopathy/trop-
lated from an infected patient and processed in similarical spastic paraparesis (HAM/TSP), an inflammatory
conditions showed 1.6% of Tax-expressing cells. Asdisease of the central nervous system.
expected, no staining was observed using an irrelevantA knowledge of which cell types harbor the virus in
monoclonal antibody (mAb) (Figure 1A). Using the sameinfected individuals is important for understanding the
method, cells infected with a Vaccinia virus recombinantbiology of the virus and the pathogenesis of HTLV-I-
for Tax stained positive, while those infected with a wild-
type Vaccinia virus were negative (data not shown).k To whom correspondence should be addressed (e-mail: c.bangham@
ic.ac.uk). We used this new flow cytometric approach to better
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Figure 1. Infection of CD81 T Cells by HTLV-I
(A) Expression of HTLV-I Tax in MT-2 cells, uninfected PBMCs, and PBMCs obtained from an HTLV-I-infected patient. The PBMCs were
cultivated for 12 hr in vitro before being harvested. The Tax protein was detected with the Lt-4 mAb, and an irrelevant mAb was used as a
control isotype.
(B) Expression of HTLV-I Tax in naturally infected CD41 and CD81 T lymphocytes. PBMCs were isolated from an HTLV-I-infected patient (TAF)
and either cultivated for 6 hr or processed fresh for the concomitant detection of Tax, CD4, and CD8 antigens.
(C) Tax mRNA detection by PCR analysis in purified CD81 T cells (96% purity) obtained from an HTLV-I-infected patient (TAF). To exclude
the possibility of false-positive signal due to contamination of purified CD81 T cells by infected PBMCs, uninfected CD81 T cells were artificially
contaminated with 10%, 5%, 2.5%, or 0% of infected PBMCs (TAF) and submitted to PCR analysis. As a control, b-actin mRNA expression
was also investigated.
characterize the phenotype of Tax-expressing PBMCs. showed a typical distribution (Bex and Gaynor, 1998) of
Tax expression in the nucleus and perforin expressionSurprisingly, the analysis showed that, in addition to
CD41 T lymphocytes, a fraction of CD81 T lymphocytes in lytic granules in the same cells (Figure 3C).
Quantitative analysis of PBMCs obtained from threealso expressed the Tax protein after 6 hr of cultivation
ex vivo (Figure 1B). To confirm infection of CD81 T cells ACs of the virus and three HAM/TSP patients revealed
in each case that a proportion of Tax-expressing lym-by HTLV-I, the expression of tax mRNA was also investi-
gated in purified CD81 T cells by the use of a semiquanti- phocytes (from 4% to 28%) were CD81 T lymphocytes.
The Tax protein is capable of transactivating both viraltative reverse PCR. As shown in Figure 1C, expression
of the tax mRNA is detected in CD81 T cells obtained and cellular genes, including CD25. Therefore, to further
confirm expression of Tax in CD81 T lymphocytes, wefrom an HTLV-I-infected patient (TAF). In contrast, tax
mRNA expression is hardly visible in uninfected CD81 determined whether Tax expression induces CD25
upregulation in CD81 T lymphocytes. As predicted, theT cells where 10%, 5%, 2.5%, or 0% of infected PBMCs
(TAF) were added before cultivation. This excludes the analysis showed that more than 55% of Tax-expressing
cells are positive for CD25 after 12 hr of cultivation, whilepossibility that the positive signal observed in purified
CD81 T cells (96% purity) obtained from an HTLV-I- none were CD25 positive after 6 hr. Similar results have
been obtained with PBMCs isolated from three differentinfected patient (TAF) is due to contamination. As ex-
pected, the level of b-actin mRNA is similar in the differ- HTLV-I-infected patients (data not shown). Furthermore,
the analysis of CD69 (early activation marker) and CD71ent samples. Expression of Tax in cytotoxic CD81 T
lymphocytes was also confirmed by fluorescence micro- (proliferation marker) expression gave comparable re-
sults. The expression of another HTLV-I antigen (p24;scopic analysis of purified CD81 T lymphocytes, which
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Table 3. Expression of HTLV-I Tax Protein in Virus-SpecificTable 1. Expression of HTLV-I p24 Protein in CD81 T
CD81 T LymphocytesLymphocytes
% of Tax ExpressionaExpression of p24 (%)a
EBV BMLF1208-288-Specific HTLV-I Tax11-19-SpecificPatient Tax-Negative CD81 T Cells Tax-Positive CD81 T Cells
Patient CD81 T Cells CD81 T Cells
TAF 0.2 44
TAF 0.0 (1.3)b 2.6 (5.3)TAN 1.3 26
TAC 0.0 (0.4) 7.6 (3.2)TAT 1.3 44
TAK ND (UN) 38.1 (1.8)
a Cells were cultivated in the presence of 20 nM of Concanamycin HH 0.0 (0.8) 4.6 (4.0)
A for 24 hr. HY 0.0 (0.3) 16.7 (0.1)
a Cells were cultivated in the presence of 20 nM of Concanamycin
A for 6 hr.
b Percentage of tetramer-positive cells in CD81 T lymphocytes.HTLV-I Gag antigen) was assayed in CD81 T lympho-
UN, undetectable; and ND, not determined.cytes of three HTLV-I-infected patients (TAF, TAN, TAT).
The analysis showed that a large proportion (from 26%
to 44%) of Tax-positive CD81 T lymphocytes also ex-
patients revealed that a proportion (2.6% to 38%) ofpressed the p24 protein after 24 hr of cultivation in vitro
Tax11–19-specific CD81 T cells was expressing HTLV-I(Table 1). Only 0.2% of Tax-negative CD81 T lympho-
Tax after 6 hr of cultivation (Table 3). In contrast tocytes expressed the p24 protein (Table 1). This fre-
Tax11–19-specific CTLs, Epstein-Barr virus BMLF1280–288-quency of p24 expression among Tax-expressing CD81
specific CTLs did not show any Tax expression (0.0%),T cells is similar to that previously observed in Tax-
even in the presence of CMA (Table 3).expressing CD41 T cells (Hanon et al., 2000). Altogether,
these results demonstrate that, in addition to CD41 T
Time Course Study of Tax Expressionlymphocytes, HTLV-I also infects CD81 T lymphocytes.
in CD81 T Lymphocytes
We have previously shown that infected CD41 T lympho-CD81 T Lymphocytes Are Infected by HTLV-I In Vivo
cytes expressing the HTLV-I Tax protein become sus-Although it is very unlikely, infected CD41 T lymphocytes
ceptible to lysis by HTLV-I-specific CTLs (Hanon et al.,could produce virions and infect CD81 T lymphocytes
2000) (CD561 NK cells did not contribute detectablyduring the short-term cultivation in vitro (Gessain et al.,
to the lysis of Tax-expressing cells). This observation1990). To exclude this possibility, the expression of Tax
suggested that HTLV-I-specific CTLs might also kill Tax-was also investigated in CD81 T lymphocytes cultivated
expressing CD81 T lymphocytes. A time course study ofin the absence of CD41 T lymphocytes. Table 2 shows
Tax expression was therefore carried out using PBMCsthat neither the depletion of CD41 T lymphocytes nor
obtained from three HTLV-I-infected patients. Figure 2Athe enrichment of CD81 T lymphocytes has a significant
shows that Tax expression in CD81 T lymphocyteseffect on the frequency of Tax expression in CD81 T
reached a maximum at 6 hr and then decreased by morelymphocytes.
than 50% during the next 18 hr. In contrast to Tax ex-
pression, the percentage of CD81 T lymphocytes re-Preferential Infection of HTLV-I-Specific
mained constant throughout the time course (data notCD81 T Lymphocytes by HTLV-I
shown), which excludes the possibility that the observedWe wished to test the possibility that HTLV-I-specific
changes in Tax expression were due to a dramaticCD81 T lymphocytes could themselves become infected
change in the frequency of CD81 T lymphocytes.with HTLV-I. Since Tax11–19 is the dominant target epitope
recognized by HTLV-I-specific CTLs in HLA-A*02011 indi-
Role of Cell-Mediated Cytotoxicity in theviduals (Jacobson et al., 1990; Kannagi et al., 1992; Par-
Disappearance of Tax-Expressing CD81 Tker et al., 1992, 1994; Bieganowska et al., 1999), infection
Lymphocytes In Vitroof HTLV-I-specific CTLs was investigated using fluores-
The perforin pathway has been shown to be essential forcent-labeled tetramers of HLA-A*0201 1 b2 microglobu-
HTLV-I-specific CTLs to mediate their cytotoxic functionlin 1 Tax11–19 peptide (Altman et al., 1996; Jeffery et al.,
against Tax-expressing lymphocytes (Hanon et al.,1999). Flow cytometric analyses of five HTLV-I-infected
2000). Therefore, to determine whether the observed
decrease in the frequency of Tax-expressing CD81 T
cells after 12 hr of cultivation is due to cell-mediatedTable 2. Expression of HTLV-I Tax Protein in CD81 T
Lymphocytes cytotoxicity, PBMCs from three patients (TAU, TAN, TW)
were cultivated for 12 hr in the presence of 20 nM ofTax Expression (%)
concanamycin A (CMA), an inhibitor of the perforin-
Patient PBMC Cultures CD82 T Cells CD81 T Cells dependent cytotoxic pathway (Kataoka et al., 1996).
TAL – 9.8 2.5 Flow cytometric analyses showed that the frequency of
CD4 depleted 0.9 2.2 Tax-expressing CD81 T lymphocytes was respectively
TAN – 1.8 1.2 2.5-, 1.7-, and 2.3-fold higher in CMA-treated cultures
CD4 depleted 0.1 0.9
than in control cultures (Figure 2B). The requirement forTAZ – ND 2.2
cell–cell contact was also investigated to further deter-CD8 enriched ND 2.8
mine the role of cell-mediated cytotoxicity in the ob-
ND, not determined.
served decrease of Tax expression. The frequency of Tax-
Immunity
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expressing PBMCs obtained from these patients (TAU,
TAN, TW) was compared in conventional cultures, where
PBMCs are cultivated in round bottom wells and there-
fore establish frequent cell–cell contacts, with other cul-
tures, in which PBMCs are cultivated with the same
volume of medium in flat bottom wells to reduce the
frequency of cell–cell contacts. Flow cytometric analy-
ses made with PBMCs cultivated for 12 hr showed that
the reduction of cell–cell contacts is associated with
an increase (2-, 1.5-, and 2-fold, respectively) in the
frequency of Tax-expressing CD81 T lymphocytes (Fig-
ure 2B), which is similar to the increase caused by CMA
treatment (Figure 2B). These observations exclude the
possibility that a putative Tax-induced suicide process
is implicated in the observed decrease of Tax expression
(Figure 2A). Furthermore, these results are consistent
with the possibility that Tax-expressing CD81 T lympho-
cytes are killed by HTLV-I-specific CTLs. Consistent with
this hypothesis, the addition of an anti-MHC class I mAb
in culture of purified CD81 T cells also prevented the
decrease in the frequency of Tax-expressing CD81 T
cells, while an anti-MHC class II antibody did not (Fig-
ure 2C).
Fratricide among HTLV-I-Infected
CD81 T Lymphocytes
The decrease in the frequency of Tax-expressing CD81
T cells in culture requires close cell-to-cell contact and
intact perforin granules. Consistent with these observa-
tions, confocal microscopic analysis (Figure 3) of cul-
tures of purified CD81 T cells showed numerous CD81
T cells with perforin lytic granules polarized toward the
point of contact with Tax-expressing CD81 T cells. Fig-
ures 3C–3F correspond to serial sections through a sin-
gle group of cells showing a perforin-expressing T cell
(boundaries shown by three large arrowheads) in con-
tact with a cell that expresses both perforin and Tax.
The granules of the cell that only expresses perforin
are polarized toward the area of contact with the Tax-
expressing cell. In contrast, the perforin granules of
neighboring CD81 T cells (e.g., small arrowheads in [F])
and those of the Tax-expressing cell itself are dispersed.
These morphological observations strongly support the
possibility that Tax-expressing CD81 T cells are being
killed by CTLs. In this case, there are two implications.
First, the level of mortality in Tax-positive CD81 T lym-
phocytes should be specifically higher than in Tax-nega-Figure 2. Role of Cell-Mediated Cytotoxicity in the Disappearance
tive CD81 T lymphocytes. Second, the presence of CMAof Tax-Expressing CD81 T Lymphocytes In Vitro
should specifically reduce this higher level of mortality(A) Time course study of Tax expression in naturally infected CD81
in Tax-positive CD81 T lymphocytes. Therefore, to testT lymphocytes. PBMCs were isolated from three HTLV-I-infected
patients (TAU, TAN, TAF), cultivated for various times, and then our predictions, a CTL assay based on the selective
processed for the detection of Tax, CD4, and CD8 antigens. propidium iodide incorporation by dead cells was used
(B) Effect of concanamycin A (CMA) and reduction of cell-to-cell (Radosevic et al., 1990; Mattis et al., 1997). For this
contact on the frequency of Tax expression in CD81 T lymphocytes.
experiment, purified CD81 T lymphocytes isolated fromPBMCs were isolated from an HTLV-I-infected patient, cultivated
five infected patients were cultivated in the presence orwith or without CMA for 12 hr, and then processed for the concomi-
absence of 20 nM of CMA for 12 hr, harvested, andtant detection of Tax and CD8 antigens. The effect of the prevention
of cell–cell contact has been investigated by comparing the frequency incubated with propidium iodide (PI) to label dead cells.
of Tax expression in CD81 lymphocytes cultivated in round bottom The concomitant detection of HTLV-I Tax and PI by flow
wells or in flat bottom wells. One representative experiment is shown. cytometry showed that, in the absence of CMA, the level
(C) Effect of anti-MHC class I or -MHC class II mAbs on the frequency
of mortality in Tax-expressing CD81 T lymphocytes wasof Tax expression in CD81 lymphocytes. PBMCs were isolated from
indeed higher than in the Tax-negative population (Fig-an HTLV-I-infected patient, cultivated with or without the mAbs for
ure 4). As predicted, in the presence of CMA, the level12 hr, and then processed for the concomitant detection of Tax and
CD8 antigens. of mortality dropped in Tax-expressing CD81 T lympho-
Fratricide among HTLV-I-Infected CD81 T Cells
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Figure 3. The Perforin Granules of CD81 T
Cells Polarize toward the Site of Contact with
Tax-Expressing CD81 T Cells
Negatively purified CD81 T cells isolated from
an HTLV-I-infected patient were cultivated for
12 hr and double immunolabeled with anti-
bodies to detect both perforin (red) and Tax
(green) expression.
(A and B) Fluorescence and transmission im-
ages of the same cells showing perforin-con-
taining granules (red) polarized toward the
Tax-expressing cells (green).
(C–F) Serial sections through a single group
of cells showing a perforin-expressing T cell
(boundaries shown by three large arrow-
heads) in contact with a cell that expresses
both perforin and Tax. The granules of the
cell that only expresses perforin are polarized
toward the area of contact with the Tax-
expressing cell. In contrast, the perforin gran-
ules of neighboring CD81 T cells (e.g., small
arrowheads in [F]) and those of the Tax-
expressing cell itself are dispersed. One rep-
resentative experiment out of three is shown.
Bars represent 10 mm.
cytes while it slightly increased in the Tax-negative pop- We show here that, in naturally HTLV-I-infected patients,
a significant proportion of CD81 T lymphocytes are alsoulation (Figure 4). Altogether, these results demonstrate
that HTLV-I-specific CTLs are capable of mediating frat- infected by HTLV-I. Interestingly, HTLV-I-specific but
not Epstein-Barr virus-specific CD81 T lymphocytesricide against Tax-expressing CD81 T lymphocytes.
were shown to be infected (Table 3). The reasons for
this apparent preferential infection of HTLV-I-specificDiscussion
CD81 T cells are unknown. However, cell-to-cell contact
(Miyoshi et al., 1981; Popovic et al., 1983) and cellularInfection and gene expression by HTLV-I in vivo have
been thought to be confined to CD41 T lymphocytes. activation (Merl et al., 1984; Krichbaum-Stenger et al.,
Figure 4. Mortality Rates in Tax-Positive and
-Negative CD81 T Lymphocytes
CD81 T lymphocytes were negatively purified
from five HTLV-I-infected patients (TAZ, TAN,
TAU, HH, HY) and cultivated in the presence
or absence of 20 nM of CMA for 12 hr. After
being harvested, cells were incubated with
propidium iodide (PI) to label dead cells and
processed to detect concomitantly Tax and
PI by flow cytometry.
Immunity
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1987) greatly enhance the transmission of HTLV-I be- and enhances LCMV persistence in vivo (Zinkernagel et
tween cells. Therefore, activation of HTLV-I-specific al., 1999).
CD81 T cells by HTLV-I-infected cells (CD41 T cells and/ In conclusion, we show here that, in addition to CD41
or HTLV-I-infected dendritic cells) might increase their T lymphocytes, CD81 T lymphocytes including HTLV-I-
susceptibility to HTLV-I infection. Dendritic cells can be specific CTLs are infected by HTLV-I. Furthermore, viral
infected with HTLV-I in vitro (Makino et al., 1999), and protein expression within CD81 T lymphocytes renders
Macatonia et al. (1992) estimated that 0.4% to 5.1% of them susceptible to fratricide mediated by virus-specific
dendritic cells were infected with HTLV-I (as determined CTLs. This could specifically impair the immune control
by in situ hybridization) in HTLV-I-positive individuals. of HTLV-I and therefore contribute to the persistence of
Finally, in HIV infection, dendritic cells have been shown HTLV-I in vivo. A comparable mechanism might also
to facilitate the transmission of the virus to CD41 T cells reduce the efficiency of the immune control of other
by promoting their activation (Geijtenbeek et al., 2000). lymphotropic viruses, such as HIV-1, CMV, or HSV-1,
Further work is required to investigate the interaction especially if the infection is selective for virus-specific
between HTLV-I-specific CD81 T cells and their target T lymphocytes.
cells.
HTLV-I infection and protein expression could have Experimental Procedures
important biological effects on CD81 T lymphocytes.
Patients and CellsHTLV-I infection has been shown to disrupt the function
Peripheral blood mononuclear cells (PBMC) were obtained fromof CTLs in vitro (Popovic et al., 1984; Yarchoan et al.,
seven HTLV-I-infected patients with a clinical diagnosis of HAM/
1986; Inatsuki et al., 1991). We also show that Tax protein TSP and four asymptomatic carriers of the virus. All patients gave
expression in CD81 T cells is associated with upregula- informed consent. PBMCs were isolated on Histopaque-1077
tion of the activation markers CD25, CD69, and CD71. (Sigma, Dorset, UK) density gradient and washed three times with
phosphate- buffered saline (PBS). A CD81 T cell isolation kit and CD4This might deregulate normal CD81 T lymphocyte bio-
microbeads (Miltenyi Biotec Ltd, Surrey, UK) were used according tological functions. Furthermore, we demonstrate that
the manufacturer’s instructions to enrich or deplete the respectiveviral protein expression in HTLV-I-infected CD81 T lym-
PBMC subpopulations. Cells were cultured at 1 3 106 per milliliter
phocytes renders them susceptible to fratricide medi- in RPMI 1640 medium (GIBCO, Paisley, UK) supplemented with 10%
ated by autologous CTLs (Figures 2, 3, and 4). Several fetal calf serum (FCS) (Sigma, Dorset, UK), 2 mM glutamine (GIBCO),
observations support this conclusion. First, reduction 100 IU/ml penicillin (GIBCO), and 100 mg/ml streptomycin (GIBCO).
In some experiments, 20 nM of concanamycin A (CMA) (Sigma), 5of cell-to-cell contact, inhibition of perforin production,
mg/ml of anti-MHC class I mAb (W6/32, IgG2a) (Serotec, Oxford,or anti-MHC class I but not anti-MHC class II antibodies
England), or 5 mg/ml of anti-MHC class II mAb (TU¨39, IgG2a) (Bectonprevented the rapid decrease in the frequency of Tax-
Dickinson UK Ltd.) was added to the culture medium. For the experi-expressing CD81 T cells observed in cultures ex vivo
ment where the requirement of cell-to-cell contact has been tested,
(Figure 2). Second, confocal microscopic analysis (Fig- the cells have been cultivated at 0.5 3 106 per milliliter.
ure 3) showed numerous CD81 T cells with perforin lytic
granules polarized toward the point of contact with Tax- Flow Cytometry
expressing CD81 T cells, which are morphological char- For the concomitant detection of Tax, CD4, CD8, and CD25 antigens,
cells were fixed in PBS containing 2% paraformaldehyde (Sigma)acteristics of the cell-mediated cytotoxicity process
for 20 min and resuspended in PBS at 48C until use. Fixed cells(Berke, 1994). Finally, a flow cytometric CTL assay (Ra-
were washed with PBS containing 7% of normal goat serum (NGS)dosevic et al., 1990; Mattis et al., 1997) demonstrated
(Sigma) and incubated with PC5-labeled anti-CD4, ECD-labeleda higher level of cell death in Tax-positive CD81 T lym-
anti-CD8, and PE-labeled anti-CD25 mAbs (Beckman Coulter, Bed-
phocytes than in Tax-negative CD81 T lymphocytes. fordshire, UK) for 15 min at room temperature. The cells were then
Furthermore, the presence of CMA specifically reduced washed and permeabilized with PBS containing 0.1% Triton X-100
the high rate of mortality in Tax-positive but not Tax- (Sigma) for 10 min at room temperature. Permeabilized cells were
washed and resuspended in PBS/7% NGS containing an anti-HTLV-Inegative CD81 T lymphocytes (Figure 4).
Tax mAb (Lt-4; IgG3) (Lee et al., 1989) or an isotype control mAbThree recent lines of evidence suggest that the class I
(Southern Biotechnology Associates, Birmingham, AL) for 20 min atMHC-restricted T cell response is highly active in HTLV-I
room temperature. The cells were then washed twice and resus-infection in vivo. First, the dominant HTLV-I antigen rec- pended in PBS/7% NGS containing FITC-labeled goat F(ab9)2 anti-
ognized by virus-specific CTLs, Tax, is subject to posi- mouse IgG3 serum (Southern Biotechnology Associates) for 20 min
tive selection in healthy HTLV-I carriers (Niewiesk et al., at room temperature. Finally, the cells were washed twice and ana-
1994). Second, the class I allele HLA-A*02 is associated lyzed by flow cytometry on a Coulter EPICS XL (Beckman Coulter).
For the concomitant detection of Tax and p24 (HTLV-I gag anti-with both protection against the HTLV-I-associated in-
gen), the cells were processed as described above for detection offlammatory disease HAM/TSP and with a reduction in
Tax, but an anti-p24 mAb (MAB8817; IgG1) (Chemicon International,the provirus load of HTLV-I (Jeffery et al., 1999). Finally,
Temecula, CA) was used in addition to the Lt-4 mAb. The anti-p24
autologous HTLV-I-specific CTLs efficiently kill Tax- Mab was then detected with a PE-labeled goat F(ab’)2 anti-mouse
expressing CD41 T lymphocytes in freshly isolated and IgG1 serum (Southern Biotechnology Associates). In addition, the
unstimulated peripheral blood mononuclear cells (Ha- CD4 and CD8 membrane antigens were detected after Tax and p24
non et al., 2000). The occurrence of fratricide within labeling in the presence of 1% mouse serum to prevent cross-
reactions.HTLV-I-infected CD81 T lymphocytes might therefore
For the concomitant detection of Tax and cell mortality by flowimpair the immune control of HTLV-I in vivo (Barchet et
cytometry, the cells were harvested and incubated for 10 min in theal., 2000), especially if the virus selectively infects HTLV-
presence of 5 mg per milliliter of propidium iodide (PI) (Sigma). Then
I-specific T lymphocytes as suggested by our data (Ta- the cells were washed twice with PBS, fixed in PBS containing 2%
ble 3). It has been similarly suggested that CTL-medi- paraformaldehyde for 20 min, and resuspended in PBS at 48C until
ated lysis of LCMV-specific B lymphocytes, infected use. Fixed cells were then washed with PBS/7% NGS and processed
as described above to detect the Tax protein.with LCMV, impairs the antibody response to the virus
Fratricide among HTLV-I-Infected CD81 T Cells
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Analysis of PBMCs for the presence of Tax11–19-specific CD81 T Berke, G. (1994). The binding and lysis of target cells by cytotoxic
lymphocytes: molecular and cellular aspects. Annu. Rev. Immunol.lymphocytes was performed by using fluorescent-labeled tetramers
of HLA-A*0201 1 b2 microglobulin 1 Tax11–19 peptide (Altman et al., 12, 735–773.
1996; Jeffery et al., 1999). PBMCs were incubated with PBS con- Bex, F., and Gaynor, R.B. (1998). Regulation of gene expression by
taining 5% FCS and Tax11–19 tetramer at 378C for 30 min. The cells HTLV-I Tax protein. Methods 16, 83–94.
were then washed three times in ice-cold PBS, fixed in PBS con-
Bieganowska, K., Hollsberg, P., Buckle, G.J., Lim, D.G., Greten, T.F.,taining 2% paraformaldehyde for 30 min at 48C, and processed as
Schneck, J., Altman, J.D., Jacobson, S., Ledis, S.L., Hanchard, B.,described above to detect the Tax, CD4, and CD8 antigens.
et al. (1999). Direct analysis of viral-specific CD81 T cells with solu-
ble HLA- A2/Tax11-19 tetramer complexes in patients with humanQuantification of tax mRNA
T cell lymphotropic virus-associated myelopathy. J. Immunol. 162,RNA was isolated using High Pure RNA Isolation Kit (Boehringer
1765–1771.Mannheim, Lewes, UK). cDNA was then synthesized using 1st
Cho, I., Sugimoto, M., Mita, S., Tokunaga, M., Imamura, F., andStrand cDNA Synthesis Kit for RT-PCR AMV (Boehringer Mannheim).
Ando, M. (1995). In vivo proviral burden and viral RNA expressionPCR reactions were carried out in 50 ml containing cDNA prepared
in T cell subsets of patients with human T lymphotropic virus type-from 10 ng of RNA with primers for HTLV-I Tax or human b-actin.
1-associated myelopathy/tropical spastic paraparesis. Am. J. Trop.Tax primers were 59-TCGCTGCCGATCACGATGCGTTTCC-39 and
Med. Hyg. 53, 412–418.59-AACACGTAGACTGGGTATCC-39. Human b-actin primers were
59-AAGAGAGGCATCCTCACCCT-39 and 59-TACATGGCTGGGGTG De Vecchis, L., Graziani, G., Macchi, B., Grandori, C., Pastore, S.,
TTGAA-39. Cycle conditions for amplification of the tax sequence Popovic, M., Gallo, R.C., and Bonmassar, E. (1985). Decline of natu-
were 1 cycle at 958C for 5 min followed by 45 cycles at 958C for 60 ral cytotoxicity of human lymphocytes following infection with hu-
s, 588C for 75 s, 728C for 90 s, and 1 final cycle at 728C for 10 min. man T-cell leukemia/lymphoma virus (HTLV). Leuk. Res. 9, 349–355.
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